There are a few incubators that focus on bio but even these don't specialize in biopharma (vs diagnostics, med tech, software stuff). Biopharma is where most o

There are a few incubators that focus on bio but even these don't specialize in biopharma (vs diagnostics, med tech, software stuff). Biopharma is where most of the venture money is (over $10B in 2017) but most companies are seeded within VC. So dealflow is very network driven. Life sci VCs, successful biopharma execs and entrepreneurs and academic key opinion leaders are good sources if they are in your network Getting to know the cell biology / biochem / bioinformatics community at your local research institution is a good way to find untapped early stage deal flow but to take advantage of this you often need to bring some domain expertise or operational expertise to bear, as a lot of the folks in academia can benefit from operations / industry support. If you can speak at a university event or guest lecture in a class that can be a time-efficient way to get into the flow of things at the institution